Clinical Trial Update: Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating subcutaneous treatment for safety and efficacy in generalized systemic lupus erythematosus has completed with results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Snippet

Sponsor: Pfizer | Conditions: Lupus Erythematosus, Systemic | Phase 2 | Status: COMPLETED | Results posted: 2017-12-19